Cambridge Audio L/R S review: Desktop speakers worth waiting for

At the first attempt, Cambridge has comprehensively crashed the ‘vaguely affordable desktop stereo speaker system’ party – ...

Luminii Launches Next-Generation LED Platform Redefining the Core of Its Architectural Linear Portfolio

Gen 2 LED architecture delivers industry-leading efficacy, color quality, precision, and system-wide performance ...
Crain's Chicago Business

Augmedics to sell its AR spine surgery system

Augmented reality medtech Augmedics is set to sell its spine surgery platform to medical equipment company VB Spine, the companies announced. The move would mean Arlington Heights-based Augmedics is ...
TravelPulse

Europe’s New Entry System Slows Arrivals at Busy Airports

Travelers heading to Europe this year may want to budget extra time upon arrival, as a new biometric border system continues to be rolled out across the region. The new Entry/Exit System (EES) is ...
Morningstar

Pulse Biosciences Presents Late-Breaking Data from nPulse™ Cardiac Catheter System First-In-Human Feasibility Study at the AF Symposium

Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse™ technology using proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced late-breaking ...
BioSpace

Pulse Biosciences Presents Late-Breaking Data from nPulse™ Cardiac Catheter System First-In-Human Feasibility Study at the AF Symposium

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse™ technology using proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) ...
IEEE

Arbitrarily Tunable Multi-Frequency Pulse Modulation Using an Active Fiber Loop for Fading-Free DAS System

Abstract: This paper proposes and demonstrates an arbitrarily tunable multi-frequency pulse modulation scheme based on an active fiber loop, which effectively suppresses the interference fading effect ...
Morningstar

Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation

Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation Pulse Biosciences, Inc. (Nasdaq: PLSE), a company ...